Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.

Saved in:
Bibliographic Details
Title: Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.
Authors: Parry CW; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Pellicano F; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Schüttelkopf AW; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Beyer KS; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland., Bower J; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Bryson A; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Cameron K; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Cerutti NM; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Clark JP; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Davidson SC; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Davies K; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Drysdale MJ; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Engelman J; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Estevan-Barber A; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Gohlke A; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Gray CH; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Guthy DA; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland., Hong M; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, Maryland 21702, United States., Hopkins A; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Hutchinson LD; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Konczal J; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Maira M; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland., McArthur D; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Mezna M; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., McKinnon H; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Nepravishta R; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Ostermann N; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland., Pasquali CC; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Pollock K; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Pugliese A; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Rooney N; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Schmiedeberg N; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland., Shaw P; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Velez-Vega C; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., West C; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., West R; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Zecri F; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Taylor JB; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
Source: Journal of medicinal chemistry [J Med Chem] 2025 May 08; Vol. 68 (9), pp. 9129-9161. Date of Electronic Publication: 2025 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40162713
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parry+CW%22">Parry CW</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Pellicano+F%22">Pellicano F</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Schüttelkopf+AW%22">Schüttelkopf AW</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Beyer+KS%22">Beyer KS</searchLink>; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bower+J%22">Bower J</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Bryson+A%22">Bryson A</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Cameron+K%22">Cameron K</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Cerutti+NM%22">Cerutti NM</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Clark+JP%22">Clark JP</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Davidson+SC%22">Davidson SC</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Davies+K%22">Davies K</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Drysdale+MJ%22">Drysdale MJ</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Engelman+J%22">Engelman J</searchLink>; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Estevan-Barber+A%22">Estevan-Barber A</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Gohlke+A%22">Gohlke A</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Gray+CH%22">Gray CH</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Guthy+DA%22">Guthy DA</searchLink>; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hong+M%22">Hong M</searchLink>; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, Maryland 21702, United States.<br /><searchLink fieldCode="AU" term="%22Hopkins+A%22">Hopkins A</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Hutchinson+LD%22">Hutchinson LD</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Konczal+J%22">Konczal J</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Maira+M%22">Maira M</searchLink>; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22McArthur+D%22">McArthur D</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Mezna+M%22">Mezna M</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22McKinnon+H%22">McKinnon H</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Nepravishta+R%22">Nepravishta R</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Ostermann+N%22">Ostermann N</searchLink>; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pasquali+CC%22">Pasquali CC</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Pollock+K%22">Pollock K</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Pugliese+A%22">Pugliese A</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Rooney+N%22">Rooney N</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Schmiedeberg+N%22">Schmiedeberg N</searchLink>; Novartis Institute for BioMedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shaw+P%22">Shaw P</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Velez-Vega+C%22">Velez-Vega C</searchLink>; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22West+C%22">West C</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22West+R%22">West R</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.<br /><searchLink fieldCode="AU" term="%22Zecri+F%22">Zecri F</searchLink>; Novartis Institutes for BioMedical Research, Inc., 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Taylor+JB%22">Taylor JB</searchLink>; Cancer Research Horizons, CRUK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2025 May 08; Vol. 68 (9), pp. 9129-9161. <i>Date of Electronic Publication: </i>2025 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40162713
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.jmedchem.4c02929
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9129
    Titles:
      – TitleFull: Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parry CW
      – PersonEntity:
          Name:
            NameFull: Pellicano F
      – PersonEntity:
          Name:
            NameFull: Schüttelkopf AW
      – PersonEntity:
          Name:
            NameFull: Beyer KS
      – PersonEntity:
          Name:
            NameFull: Bower J
      – PersonEntity:
          Name:
            NameFull: Bryson A
      – PersonEntity:
          Name:
            NameFull: Cameron K
      – PersonEntity:
          Name:
            NameFull: Cerutti NM
      – PersonEntity:
          Name:
            NameFull: Clark JP
      – PersonEntity:
          Name:
            NameFull: Davidson SC
      – PersonEntity:
          Name:
            NameFull: Davies K
      – PersonEntity:
          Name:
            NameFull: Drysdale MJ
      – PersonEntity:
          Name:
            NameFull: Engelman J
      – PersonEntity:
          Name:
            NameFull: Estevan-Barber A
      – PersonEntity:
          Name:
            NameFull: Gohlke A
      – PersonEntity:
          Name:
            NameFull: Gray CH
      – PersonEntity:
          Name:
            NameFull: Guthy DA
      – PersonEntity:
          Name:
            NameFull: Hong M
      – PersonEntity:
          Name:
            NameFull: Hopkins A
      – PersonEntity:
          Name:
            NameFull: Hutchinson LD
      – PersonEntity:
          Name:
            NameFull: Konczal J
      – PersonEntity:
          Name:
            NameFull: Maira M
      – PersonEntity:
          Name:
            NameFull: McArthur D
      – PersonEntity:
          Name:
            NameFull: Mezna M
      – PersonEntity:
          Name:
            NameFull: McKinnon H
      – PersonEntity:
          Name:
            NameFull: Nepravishta R
      – PersonEntity:
          Name:
            NameFull: Ostermann N
      – PersonEntity:
          Name:
            NameFull: Pasquali CC
      – PersonEntity:
          Name:
            NameFull: Pollock K
      – PersonEntity:
          Name:
            NameFull: Pugliese A
      – PersonEntity:
          Name:
            NameFull: Rooney N
      – PersonEntity:
          Name:
            NameFull: Schmiedeberg N
      – PersonEntity:
          Name:
            NameFull: Shaw P
      – PersonEntity:
          Name:
            NameFull: Velez-Vega C
      – PersonEntity:
          Name:
            NameFull: West C
      – PersonEntity:
          Name:
            NameFull: West R
      – PersonEntity:
          Name:
            NameFull: Zecri F
      – PersonEntity:
          Name:
            NameFull: Taylor JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 05
              Text: 2025 May 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1520-4804
          Numbering:
            – Type: volume
              Value: 68
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Journal of medicinal chemistry
              Type: main
ResultId 1